Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis (Q40775185)

23 September 2017

Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis (English)

1 reference

23 September 2017

1 reference

Chen Q

1

1 reference

23 September 2017

Samaranayake LP

2

1 reference

23 September 2017

Zhen X

3

1 reference

23 September 2017

Luo G

4

1 reference

23 September 2017

Nie M

5

1 reference

23 September 2017

Li B

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

23 September 2017

1 reference

23 September 2017

35

1 reference

23 September 2017

6

1 reference

23 September 2017

548-553

1 reference

Apoptosis by death factor

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

1 reference

7 January 2021

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Activated B cells express functional Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Identification of the Fas antigen in human gingiva

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Immunohistochemical detection of Fas antigen in oral epithelia

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Apoptosis-associated markers in oral lichen planus.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Apoptosis in oral erythema multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900029-9

7 January 2021

10.1016/S1368-8375(99)00029-9

Identifiers

DOI

1 reference

23 September 2017

1 reference